Home Blog Page 154

Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

BUENOS AIRES, Argentina, Aug. 27, 2026 /PRNewswire/ — Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company’s biologics production capacity and reinforcing its ability to support potential international demand.

Biosidus works to improve people's quality of life.
Biosidus works to improve people’s quality of life.

The expansion strengthens Biosidus’ industrial platform at a time when healthcare systems are placing increasing emphasis on manufacturing reliability, continuity of treatment and diversified sources of complex biologic medicines.

Developed and manufactured in Argentina, Biosidus’ agalsidase beta, its biosimilar enzyme replacement therapy for Fabry disease, represents a significant milestone in the company’s biotechnology platform and its growing focus on treatments for rare diseases.

With additional production capacity, Biosidus is strengthening its international supply capabilities and is prepared to engage with partners and health authorities evaluating sustainable and reliable sources of agalsidase beta supply.

“Continuity of treatment is particularly critical for patients living with rare and chronic diseases. Expanding our productive capacity reinforces our commitment to making Biosidus’ biotechnology capabilities available to healthcare systems seeking sustainable and reliable access to high-quality biologic medicines,” said Mario Koch, Director of Rare Diseases.

After launching agalsidase beta in Argentina in 2025, Biosidus is advancing the international expansion of its program and is available to evaluate extraordinary supply requirements in markets where the applicable regulatory pathways allow it.

The new bioreactor capacity is part of Biosidus’ broader strategy of combining scientific capabilities, local manufacturing, industrial investment and international expansion to increase access to complex biologic therapies.

About Biosidus

Biosidus is an Argentine biotechnology company specializing in the development, manufacturing and commercialization of biosimilar medicines. With more than 40 years of experience in biotechnology and a presence in international markets, the company develops and manufactures complex biologic medicines across multiple therapeutic areas.

Seclore and Glean Partner to Bring Context-Aware, Persistent Sensitivity and Security Controls to the Enterprise

The integration combines Glean’s enterprise AI platform and enterprise data with Seclore ARMOR’s Data Security Intelligence layer – giving regulated organizations context-aware sensitivity classification and the remediation controls to act on it.

SANTA CLARA, Calif., Aug. 27, 2026 /PRNewswire/ — Seclore, the enterprise Data Security Intelligence company, today announced an integration between ARMOR DSPM and Glean, the leading enterprise AI platform. ARMOR DSPM uses Glean’s contextual data as the foundation for sensitivity classification, gives customers a unified remediation toolkit to act on what’s identified, and writes labels directly onto source files where they persist and remain readable by Glean. For Glean customers in financial services, healthcare, legal services, and government, the integration builds on Glean’s secure foundation with a faster path to AI-ready data identification and control across their full estate.

Seclore-X-Glean
Seclore-X-Glean

Context-Aware: Classification That Reflects How the Enterprise Actually Uses Data

Glean’s Enterprise Graph indexes data across every system an organization uses, mapping how content, people, and work connect. ARMOR DSPM works with the document content and metadata, using them as the input to its classification engine and assigning sensitivity, information type, and exposure risk based on what each file actually contains. The same classification context drives mapping to GDPR, HIPAA, India’s DPDP Act, and other regulatory frameworks. Glean customers get classification that operates across the same breadth of data Glean has already indexed — not a parallel discovery process on a subset of systems.

Actionable: Remediation and Posture Management Built In

Identification is the start, not the end. Once ARMOR DSPM has classified sensitive data, customers act on it through ARMOR’s remediation toolkit: including natively integrated EDRM for persistent, file-level encryption and usage controls that travel with the file across users, systems, and external recipients; access control that adjusts who can open, share, or modify data based on sensitivity and context. For Glean customers, content surfaced through Glean’s secure, permissions-aware platform can remain governed by that same persistent control framework.

Persistent: Labels That Travel With the Data

ARMOR DSPM writes classifications directly onto source files. Labels persist with the file independently of any platform: holding across indexing cycles, following the data between systems, and remaining intact whether the file is opened in its source application or surfaced through Glean. Because the label lives in the file itself, any system that reads the file sees the same classification.

What This Means for Glean Customers in Regulated Industries

For Glean customers in financial services, healthcare, legal services, and government, the integration helps organizations move faster with AI while maintaining the controls regulated environments require. 

Accelerated classification at enterprise breadth. ARMOR DSPM uses Glean’s indexed data to bootstrap sensitivity classification across the systems Glean already covers, shortening time-to-coverage. ARMOR connectors are deployed where remediation actions are required.

Identification connects directly to action. Classification, posture management and EDRM-based protection operate as one control model – sensitive data isn’t just discovered, it’s protected.

Compliance proof at enterprise breadth. Continuous mapping to applicable regulatory frameworks gives customers a defensible posture across the same breadth Glean has established.

“Glean has built the industry’s most comprehensive enterprise AI platform, and the enterprise context graph at its core indexes data across every system the enterprise relies on. With ARMOR, Glean customers get sensitivity classification across that same breadth, EDRM-based protection that travels with the file, and a defensible compliance posture that holds up across regulators. For regulated industries, that means a faster path from identification to control,” said Dr. Vishal Gauri, CEO, Seclore.

“Regulated industries want to move faster with AI, but they also need confidence in how sensitive information is handled. By combining Glean’s enterprise context layer with Seclore ARMOR, customers can identify important data with more context, connect those insights to the right controls, and bring AI into more regulated workflows with greater confidence. It’s a strong example of how Glean’s ecosystem helps customers bring trusted AI into more regulated, high-value workflows,” said Zubin Irani, VP of Partnerships, Glean.

Availability

The integration is available now for organizations running ARMOR DSPM and Glean.

About Seclore

Seclore is the Data Security Intelligence company for the era of enterprise AI. As AI systems increasingly read, generate, and act on data without direct human oversight, organizations need more than visibility – they need intelligence, control, and proof. Seclore ARMOR brings together data discovery, contextual intelligence, persistent protection, continuous enforcement, and usage insight within a single control model. By securing the data itself and ensuring protection travels with it, Seclore enables organizations to adopt AI confidently, demonstrate compliance continuously, and maintain trust across people, partners, and AI systems. To know more, visit https://www.seclore.com/glean/

Media Contact:

Isaac Roybal
isaac.roybal@seclore.com 

 

I.S.T. Corporation Introduces White TORMED®, a New Polyimide Film Platform for Spacecraft Thermal Control

At just 25 microns, the white polyimide film combines controlled thickness and low mass with a finished-film format designed to simplify spacecraft thermal-control manufacturing and support integrated functionality.

SALT LAKE CITY, Aug. 27, 2026 /PRNewswire/ — I.S.T. Corporation introduced White TORMED®, a new white polyimide film platform for spacecraft thermal-control applications, at the 40th Annual Small Satellite Conference (SmallSat 2026).

Building on 45 years of polyimide expertise and the continued development of TORMED® for space applications, I.S.T. Corporation began with a material question: Could thermal-control functionality be incorporated directly into a lightweight, flexible polyimide film? That exploration led to White TORMED®.

White TORMED® is a finished, film-based design option that combines controlled thickness, low mass and repeatable thermal performance. Its flexible film format can simplify thermal-control manufacturing by replacing repeated coating, curing and drying steps with direct film application. The non-fluoropolymer film is designed for direct integration with composite structures and functional layers, including metals, and for adhesive-free co-curing with prepreg—a patent-pending integration technology that simplifies assembly and eliminates additional bonding steps.

A thin-film platform for thermal performance and manufacturing efficiency

Unlike a coating formed on the spacecraft surface, White TORMED® is precision-manufactured to its target thickness before application and supplied as a finished film. At only 25 microns, the concept presented at SmallSat is designed to bring together:

  • Controlled and more consistent thickness across applicable surfaces, including edges and corners.
  • Repeatable thermal performance with minimal added mass.
  • A finished-film format that can replace days of coating, curing and drying with direct film application, significantly reducing manufacturing time, labor and processing cost.
  • A non-fluoropolymer film designed for direct integration with composite structures and functional layers, including metals, and for adhesive-free co-curing with prepreg—a patent-pending integration technology that simplifies assembly and eliminates additional bonding steps.

Built on the TORMED® material platform

White TORMED® builds on I.S.T. Corporation’s proprietary transparent polyimide film platform. TORMED® combines optical transparency, outgassing below the detection limit, mechanical flexibility, electrical insulation, and compatibility with deposited metals and other functional layers. TORMED® has been independently evaluated, exposed in orbit, and selected for commercial space applications.

Transparent TORMED® samples were included in the Euro Material Ageing (EMA) experiment, a European materials-exposure program developed through collaboration among CNES, CNRS and ESA and conducted on the Bartolomeo external platform aboard the International Space Station. The samples completed approximately one year of exposure and returned to Earth for post-flight evaluation. These results provide technical context for the broader material platform; post-flight evaluation is continuing.

Transparent TORMED® has also been selected as a protective cover film for silicon solar modules in commercial satellite applications, with production and supply preparations progressing. This connects scientific validation with practical spacecraft use.

Powered by TORMED®  |  One Material. A New Approach to Spacecraft Design.

What I.S.T. Corporation presented at SmallSat 2026

The presentation, “A New Approach to Spacecraft Design: Introducing White TORMED®,” gave participants – and now the wider market – a concise view of the commercialization and scale-up roadmap:

  • The current White TORMED® concept, its 25-micron thermal performance, manufacturing-efficiency benefits and film-platform value.
  • The technical foundation provided by transparent TORMED® and its space-use progress.
  • A demand-led scale-up roadmap from A4 sheets to pilot and wide-roll production.

Evaluation and scale-up roadmap

White TORMED® A4 sheets are available now for evaluation. I.S.T. Corporation is targeting the start of pilot production for a 300 mm-wide roll in November 2026. The roadmap presented at SmallSat includes a market review and investment decision in September 2027, followed by a conditional target for mass production of 1,000+ mm-wide rolls in fall 2028. These future steps remain subject to evaluation results, market demand, technical readiness and investment approval.

White TORMED® — Ready for Evaluation and Application

I.S.T. Corporation invites spacecraft manufacturers, subsystem suppliers and integrators to evaluate or purchase White TORMED® for their applications. For teams seeking application-specific solutions, I.S.T. can also support technical collaboration in thermal control, functional-film integration, RF concepts and composite-structure integration.

We make the material. You design what it becomes. Teams ready to explore the next application of TORMED® are invited to contact I.S.T. Corporation through the information below. Let’s find out together.

About TORMED®

TORMED® is I.S.T. Corporation’s proprietary transparent polyimide roll film. It is engineered for applications requiring optical transparency, thermal resistance, mechanical flexibility, outgassing below the detection limit, electrical insulation, and compatibility with functional coatings and deposited layers. Application concepts include solar-array cover films, flexible optical solar reflectors, antenna-integrated films, space electronics and tapes. White TORMED® is moving toward pilot roll production.

About I.S.T. Corporation

I.S.T. Corporation is a materials innovation company that develops high-performance polymers, films, fibers, composites and proprietary processing technologies for demanding industrial and advanced-technology applications. Its approach combines molecular design, material formulation, production-process development and scalable manufacturing.

TORMED information: https://ist-caretp.com/materials/tormed/
SmallSat conference: https://smallsat.org/

SenseTime Records First‑Ever Profit in First Half of 2026 “Models + Token Factory + Agent Harness” Framework Unlocks High‑Value Commercialization


HONG KONG SAR – Media OutReach Newswire – 26 August 2026 – SenseTime Group Inc. (“SenseTime” or the “Company”; Stock Code: 0020.HK) today announced its results for the first half of 2026. During the Reporting Period, the Group recorded total revenue of RMB2.91 billion, representing a year‑on‑year (“YoY”) increase of 23.4%, and gross profit of RMB1.21 billion, up 32.9% YoY. Gross profit margin reached 41.4%, an increase of 2.9 percentage points YoY. The Group also introduced recurring revenue (“RR”) for the first time, which totaled RMB1.14 billion and accounted for 39.3% of total revenue. The Group recorded a net profit of RMB620 million under International Financial Reporting Standards (“IFRS”), marking its first IFRS profit since its public listing. Generative AI revenue reached RMB2.33 billion, representing nearly 80% of the Group’s total revenue, while overseas business revenue increased 127% YoY, significantly outpacing the Group’s overall growth rate. While delivering healthy growth in revenue and gross profit, the Group continued to improve operating efficiency, with core operating losses narrowing significantly. Non‑IFRS adjusted net loss was RMB390 million, narrowing by 67.3% YoY.

The Group continued to accelerate the large‑scale commercial deployment of its AI capabilities, building system‑level AI capabilities around the framework of “one model system, one Token Factory, and one Agent Harness” to advance AI from intelligence generation toward end‑to‑end task execution and transform these capabilities into scalable commercial value.

Dr. Xu Li, Chairman of the Board and CEO of SenseTime, said: “SenseTime’s three-pillar core capability framework, built around ‘one model system, one Token Factory, and one Agent Harness’, uses a unified model system to continuously push the boundaries of intelligence, leverages infrastructure and optimization capabilities to reduce Token costs and strengthen cost‑based pricing power, and deploys agents deeply integrated into enterprise and individual workflows to deliver complete task execution capabilities. This framework enables SenseTime to move beyond pure price competition and create sustainable commercial value through differentiated technologies and services. At the same time, it allows us to expand our user base, drive recurring revenue growth, and lay a solid foundation for the Group’s high‑quality development.”

One Model System: Advancing Native Multimodal Intelligence and Long‑Horizon Agents with Global Leading Performance

In 2026, SenseTime released a series of models at a rapid pace, spanning native multimodal unification, visual perception and reasoning, controllable generation, long‑horizon agents, spatial intelligence, and physical world models. These included the NEO‑Unify architecture; SenseNova U1, U1.5 and U1.5‑Lite; SenseNova Vision; the office‑focused multimodal agent SenseNova 6.8‑Flash‑Lite; the content creation model SenseNova U1‑Pro; the spatial intelligence model SenseNova SI‑8B; and the Kairos 3.1 world model co‑developed with Ace Robotics. Across multiple core benchmarks, these models matched or outperformed leading international models, including Gemini, GPT, and DeepSeek. Less than four months after the U1 series was open‑sourced, the three projects had collectively garnered more than 11,000 stars on GitHub.

SenseTime is advancing from digital intelligence toward physical AGI through the closed‑loop framework of “architectural innovation, system capabilities, and high‑value delivery,” continuously translating technological breakthroughs into real-world applications and commercial value.

Token Factory: Upgrading from Compute Provisioning to Scaled Intelligence Production

SenseTime’s SenseCore is evolving into a production‑oriented Token Factory. Through integrated model and infrastructure optimization, as well as capabilities in model adaptation, inference optimization, heterogeneous scheduling, energy management and global service delivery, the Token Factory not only expands Token output and lowers unit costs, but also continuously enhances the reasoning, understanding, generation, and execution capabilities embedded in each Token.

In July 2026, SenseCore delivered an average daily Token service volume of 2.4 trillion, representing a YoY increase of approximately 22 times. As of the date of this announcement, the Group’s total deployed computing power had reached 48,000 Petaflops (P).

The Token Factory provides strong support for SenseTime in advancing the performance boundaries of its foundation models and scaling their commercial deployment. It has tripled the training speed for long‑context Agent models, increased image and video generation efficiency sixfold, improved reinforcement learning training efficiency, and shortened the cycle from model R&D validation to large‑scale deployment to just one week. In addition to supporting the SenseNova foundation model, the Token Factory now serves four external foundation model providers, establishing differentiated capabilities across high‑complexity computing domains, including AI for Science (“AI4S”), video generation, embodied intelligence, world models, and city‑level intelligent applications.

In addition, the Group remains committed to advancing the domestic compute ecosystem, increasing the MFU (Model Floating‑Point Utilization) of mainstream domestic chips by up to 2.5 times compared with the baseline levels established by chip manufacturers. SenseNova U1 has achieved Day 0 adaptation across more than ten domestic chip platforms.

Through compute‑energy synergy, the Company continues to reduce the unit cost of intelligence. During the Reporting Period, its Compute‑Energy Synergy Agent achieved load forecasting accuracy of 96% and generated cumulative electricity cost savings of more than RMB12 million. For every 10,000P of computing power, annual carbon emissions were reduced by 24,000 tons.

Agents Accelerate Adoption Across Enterprise and Consumer Markets, Delivering Value Through Workflow Integration and Enhanced Everyday Experiences

Building on its model and Token capabilities, SenseTime connects models, knowledge, tools, and workflows through a unified Agent Harness, transforming underlying AI capabilities into end-to-end task delivery solutions for enterprise and individual users.

The Group’s agents are rapidly expanding across both enterprise and personal workflows. During the Reporting Period, they served more than 1,000 enterprise customers across over 20 key industries, including education, government, marketing, logistics, banking, and insurance. The Office Agent, Raccoon, has served major enterprises including Lenovo, Ping An Technology, China’s three major telecommunications operators, JD.com, and Kylin Software. Total users increased more than fivefold YoY, enterprise users grew more than sixfold, and monthly active users on the cloud platform increased nearly tenfold. In addition, the video‑generation agent Seko reached a daily video production volume of 10,000 minutes. Content created on the platform has amassed an estimated 1.5+ billion views across short‑video platforms, including 10 short-form dramas that have each surpassed 100 million views. AI productivity solutions are also expanding beyond large organizations to serve smaller teams and One‑Person Companies (OPCs). In the consumer market, the Kapi series of agents, covering use cases such as health, finance, and content creation, has surpassed 45 million cumulative users.

Computer Vision remains a strategic gateway for the Group’s expansion into industry verticals and overseas markets. During the Reporting Period, revenue from the business reached RMB500 million, accounting for approximately 17% of the Group’s total revenue. The business extended across more than 20 countries and regions and served more than 4,500 customers worldwide, with recurring customers contributing 67% of revenue.

Bridging Digital and Physical Intelligence, Unlocking Ecosystem Value

SenseTime continued to invest in frontier areas, including world models and embodied intelligence, intelligent terminals, smart healthcare, and chips. The increase in the valuation of certain AI ecosystem investments generated fair‑value gains, contributing to the Group’s first‑ever IFRS profit and reflecting the gradual realization of financial value from our ecosystem assets. Beyond short‑term investment returns, the more significant long‑term value of these ecosystem investments lies in enabling the Group gain early access to frontier domains, continuously acquire real‑world tasks, data, and feedback, and further strengthen SenseTime’s unified multimodal models and system‑level delivery capabilities.

SenseTime is deepening its “Three-pillar Framework”: one model system to raise the ceiling of intelligence and expand agents’ ability to handle complex tasks; one Token Factory to improve quality and efficiency, reduce costs, and enhance global delivery capabilities; and one Agent Harness to integrate multimodal models with the Token Factory, enabling AI to complete end‑to‑end tasks in real-world scenarios.

Looking ahead, SenseTime will continue to advance the iteration of multimodal agents, driving the evolution of the Token Factory from pricing based on Token volume to pricing based on task outcomes. The Group will also deepen the application of multi‑agent collaboration across enterprise, individual, and OPC workflows, delivering efficient and reliable productivity solutions to users.

Hashtag: #SenseTime

The issuer is solely responsible for the content of this announcement.

About SenseTime

Founded in 2014, SenseTime is a leading artificial intelligence (AI) software company, committed to its mission of “creating a better AI-empowered future through original innovation”. The Company continues to lead cutting-edge AI research while accelerating the large-scale commercialization of AI technologies.

Leveraging deep academic expertise and strong in-house innovation capabilities, SenseTime continues to enhance its industry-leading multimodal, multi-task general AI capabilities, while fostering a vibrant developer ecosystem through structured open-source initiatives.

SenseTime’s business spans Generative AI, Vision AI, and emerging innovation-driven segments. Underpinned by SenseCore, its next-generation AI infrastructure, the Company integrates computing power, algorithms, and platforms to enable scalable AI deployment. Building on this foundation, SenseTime has developed the SenseNova foundation model series, delivering cost-efficient capabilities across a wide range of general AI tasks. SenseTime continues to lead the global Vision AI market, ranking No.1 worldwide by market share. Its SenseFoundry platform integrates years of accumulated computer vision expertise with advanced multimodal foundation models, providing stable and efficient Vision AI solutions to industries worldwide.

SenseTime is listed on The Stock Exchange of Hong Kong, with operations spanning more than a dozen countries and regions.

ViewX Liber and Immer Officially Launch on Kickstarter, Reach 1,000% of Funding Goal in 30 Minutes

ViewX’s glasses-free Spatial AI 3D displays surpass 10× their Kickstarter funding goal within the first 30 minutes, with the campaign reaching 1880% funded shortly after launch.

LOS ANGELES, Aug. 26, 2026 /PRNewswire/ — ViewX, a developer of next-generation spatial display technology, today announced the official Kickstarter launch of its ViewX Liber 15.6-inch and ViewX Immer 27-inch glasses-free Spatial AI 3D displays. The campaign saw strong early support from backers, reaching 1,000% of its funding goal within just 30 minutes of launch.

ViewX Kickstarter Project
ViewX Kickstarter Project

Since going live, the campaign has continued to gain momentum and has reached 1880% funded as of August 26, 2026, reflecting strong early interest in ViewX’s approach to glasses-free spatial 3D.

The launch follows ViewX’s earlier product announcement, which introduced Liber and Immer and outlined the company’s vision for combining glasses-free 3D display technology, AI-powered processing, high-speed eye tracking and an expanding 3D software ecosystem.

With the Kickstarter campaign now live, ViewX is moving from product introduction to its next phase: bringing its spatial display technology to early adopters and building a growing community around glasses-free 3D.

A Strong Start on Kickstarter

Reaching 1,000% of its funding goal within the first 30 minutes marks an important milestone for ViewX and demonstrates early demand for a new generation of spatial display technology.

The campaign’s early momentum comes from a combination of ViewX’s existing community, technology enthusiasts, gamers and early adopters interested in experiencing glasses-free 3D.

“Seeing the campaign reach 1,000% of its goal within the first 30 minutes was an incredible moment for our entire team,” said Gavin, CEO of ViewX. “We have spent years working on the technology behind ViewX, and seeing people respond so quickly to our vision is extremely encouraging. This is not only the launch of two displays—it is the beginning of a larger spatial 3D ecosystem that we want to build together with our users and community.”

Beyond the Launch: Building a Spatial 3D Ecosystem

While the Kickstarter campaign provides the first opportunity for consumers to purchase ViewX Liber and Immer, the company sees the launch as the beginning of a broader platform.

ViewX is building an expanding ecosystem that combines display hardware, AI processing and dedicated software to support a growing range of 3D experiences.

The ecosystem currently supports 100+ games, with compatibility continuing to expand through applications including SpatialGateway, DepthTransformer and 3D Playground.

ViewX also supports a growing range of 3D technologies and applications, including ReShade, Portal VR, Oku3D and Geo-11, helping expand the types of games and content that can be experienced in spatial 3D.

The ecosystem is being developed in collaboration with Tencent Games, combining gaming expertise with ViewX’s display and spatial computing technology.

Designed for Glasses-Free 3D

ViewX Liber and Immer are designed to provide immersive spatial 3D without requiring users to wear dedicated 3D glasses.

The displays combine 4K UHD resolution, high-speed eye tracking, AI-powered 2D-to-3D conversion and dedicated on-display 3D processing.

Users can switch between conventional 2D viewing and glasses-free spatial 3D on the same display, while ViewX’s software ecosystem provides additional options for gaming and 3D content.

The ViewX Liber 15.6-inch focuses on portability and flexibility, making it suitable for gaming, entertainment, creative work, presentations and professional demonstrations.

The ViewX Immer 27-inch brings the same core spatial display technology to a larger format for gaming, entertainment, content creation and professional visualization.

From Gaming to Professional Applications

Gaming is one of the primary applications for ViewX, but the company is developing its spatial display technology for a wider range of use cases, including:

  • Video and entertainment
  • Sports viewing
  • Healthcare and medical visualization
  • Automotive
  • Engineering and design
  • Education and training
  • Spatial computing

By combining glasses-free 3D optics, AI processing and software, ViewX aims to create a flexible spatial display platform that can evolve across both consumer and professional applications.

Kickstarter Campaign Now Live

The ViewX Liber and Immer Kickstarter campaign is now officially live, with early-bird rewards available for a limited time.

The campaign currently stands at 1880% funded, following its initial milestone of reaching 1,000% of its funding goal within the first 30 minutes.

Early supporters can visit the Kickstarter campaign to explore the available models, configurations and launch rewards.

The Kickstarter campaign is available now at:

https://www.kickstarter.com/projects/viewx/viewx-liber-glass-free-spatial-ai-3d-display

About ViewX

ViewX is a multidisciplinary technology company developing glasses-free Spatial AI 3D display technology. Combining expertise in display technology, optical engineering, embedded hardware and AI software, ViewX is building a new generation of spatial displays for gaming, entertainment, creative work and professional applications.

ViewX: 3D Everything

Media Contact
ViewX Limited
service@viewx3d.com
www.viewx3d.com

GIGABYTE Partners with AMD to Bring Onimusha: Way of the Sword Game Bundle to Gamers

TAIPEI, Aug. 26, 2026 /PRNewswire/ — GIGABYTE, the world’s leading computer brand, announced the Onimusha: Way of the Sword Game Bundle for eligible graphics cards and gaming desktops powered by the latest AMD technologies. Featuring select products equipped with AMD Radeon™ RX 9070 XT, RX 9070, or RX 9070 GRE graphics, the bundle brings together the AMD RDNA™ 4 architecture, advanced ray tracing, and AMD HYPR-RX technologies with GIGABYTE’s WINDFORCE cooling system and patented Hawk fan to deliver high-performance gaming for the highly anticipated action title.

GIGABYTE Partners with AMD to Bring Onimusha: Way of the Sword Game Bundle to Gamers
GIGABYTE Partners with AMD to Bring Onimusha: Way of the Sword Game Bundle to Gamers

The GIGABYTE Radeon™ RX 9070 XT, RX 9070, and RX 9070 GRE series graphics cards harness the AMD RDNA™ 4 architecture to deliver enhanced gaming performance and advanced ray tracing for immersive visuals. AMD HYPR-RX further combines performance-enhancing technologies to deliver smoother, more responsive gameplay. Complementing GPU performance, GIGABYTE’s WINDFORCE cooling system incorporates the Hawk fan to increase air pressure by up to 53.6% and air volume by up to 12.5%, supporting stable performance during demanding gaming sessions.

The game bundle is available with selected AORUS PRIME 5 gaming desktops powered by the AMD Ryzen™ 7 9800X3D processor. Designed for high-performance gaming, the AORUS PRIME 5 combines an all-around cooling solution with comprehensive connectivity for a streamlined plug-and-play experience.

From August 25 to September 26, 2026, gamers who purchase eligible GIGABYTE Radeon™ RX 9070 XT, RX 9070, or RX 9070 GRE series graphics cards or selected AORUS PRIME 5 AP551 desktops from participating retailers or e-tailers can receive an Onimusha: Way of the Sword coupon code through AMD. The game launches on September 4, 2026, and coupon codes must be redeemed by October 24, 2026. For more information about the campaign, eligible products, participating retailers, and redemption details, please visit the campaign page.

Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth

Results Highlights for Interim Results ended 30 June 2026
Revenue reached RMB1,006.5 million, increasing by 21.0% YoY
Gross profit amounted to RMB341.7 million, increasing by 0.7% YoY
Gross profit margin was 34.0%

HONG KONG, Aug. 26, 2026 /PRNewswire/ — On August 26, 2026, Viva Biotech Holdings Group (“the Group” or “the Company”, stock code: 1873.HK) announced that the Group’s revenue amounted to RMB1,006.5 million and gross profit of RMB341.7 million, representing a gross margin of 34.0%. Overall, the Group’s total revenue grew by approximately 21.0% year-on-year, primarily driven by the significant contribution from Langhua Pharmaceutical’s CDMO business, under which one peptide project has entered the commercial production phase and the other small-molecule project has reached the PPQ phase. In addition, in the first half of 2026, the Group recorded a net profit of RMB100.9 million and an adjusted non-IFRS net profit of RMB128.3 million, both representing a decline compared with the corresponding period of last year. This was mainly attributable to a decrease in investment income contributions during the Reporting Period, unfavorable foreign exchange movements and increased R&D expenses associated with new business development.

CRO Revenue Growth Set for Recovery, with AI-Driven Drug R&D Leading a New Paradigm in Drug Discovery

In the first half of 2026, the Group’s CRO revenue amounted to RMB405.1 million; adjusted gross profit for the corresponding period reached RMB173.7 million. Backed by a strong order backlog and the ongoing expansion of AI and other new technology platforms, the Company is expected to maintain a full-year growth rate in 2026 at or above its current level.

The Group’s cumulative number of CRO clients increased to 1,984, including the top 10 global pharmaceutical companies, with the top 10 clients accounting for 26.6% of CRO revenue.

As of June 30, 2026, the Company had cumulatively delivered over 108,163 protein structures to clients, of which approximately 9,278 were newly delivered in the first half of 2026. Cumulatively, over 2,557 independent drug targets have been studied, with 212 newly delivered in the first half of 2026. The number of delivered independent drug targets grew markedly, driven by the rapid advancement of AI-powered drug discovery and the resulting surge in wet-lab demand. The Company continues to lead the industry globally in protein structure determination. New modality offerings, including peptides, antibodies, XDCs, and PROTACs/molecular glues, accounted for approximately 17.7% of total CRO revenue, representing a year-on-year increase of nearly 10.7%.

As of June 30, 2026, CADD/AIDD had cumulatively participated in 228 projects, with 92 cumulative clients having procured CADD/AIDD services. Revenue contribution from AI-empowered projects accounted for approximately 14.0% of total CRO revenue. A deep collaboration with a global industry leader advanced our AI-driven “dry-wet closed-loop” model, laying a foundation for future MNC partnerships. The CADD/AIDD team launched the MARS multimodal integrated algorithm platform, leveraging Pep2MARS to establish a strong competitive advantage in designing peptides, cyclic peptides, and complex macrocycles. Through the comprehensive upgrade of its three underlying modules, V-Scepter, V-Orb, and V-Mantle, the platform will significantly boost drug design efficiency and accelerate practical applications.

CDMO Commercial Manufacturing Fuels Revenue Growth; CMC Segment Successfully Achieves Profitability

During the Reporting Period, two new CDMO commercialization projects were successfully landed. Through structural adjustment and optimization of its client portfolio, the CMC business has continuously improved project delivery rates, and has successfully achieved a turnaround from loss to profitability.

For the first half of 2026, Langhua Pharmaceutical recorded total revenue of RMB601.4 million, representing a year-on-year increase of approximately 47.0%. Adjusted gross profit totaled RMB175.1 million, up approximately 12.9% year-on-year. The revenue growth was primarily driven by two new CDMO commercialization projects. A peptide project has entered the commercial stockpiling stage, and a small-molecule project is currently at the PPQ production stage. Meanwhile, the API and the intermediates and formulations business are expected to gradually recover in the second half of the year. As of June 30, 2026, Langhua Pharmaceutical had served a cumulative total of 920 clients, with a 100.0% retention rate among its top ten customers. The current total production capacity stands at 860 cubic meters, which is sufficient to support the actual commercial production of new commercialized products over the next two years. In addition, an additional 400 cubic meters of capacity is being constructed to cater to the future volume growth of new molecule commercial production.

In 2025, the Group established a new PPO (Peptides, Proteins and Oligo Nucleotides) business unit. It is also one of the Group’s key strategic focuses for future development. The unit has already completed peptide CMC-related capabilities and team assembly. During the Reporting Period, the unit delivered 21 peptide projects accumulatively, with 19 projects currently in progress. Going forward, the PPO business unit will continue to strengthen its technological capabilities in peptides, conjugated drugs, and small nucleic acids.

Exit Proceeds to Be Deployed Towards Incubation of New Projects

During the Reporting Period, the Group realized aggregate cash proceeds of approximately RMB218.4 million from successful exits of several incubation portfolio companies over the past year and in the first half of this year. The Company plans to deploy a portion of such proceeds towards incubating new projects, leveraging its existing AI+SBDD dry-wet experimental platform. As of June 30, 2026, the Group had invested in and incubated a cumulative total of 93 start-up companies, with a cumulative total of nearly 232 pipelines under development, of which 188 are in the preclinical stage and 44 have advanced into the clinical stage. To date, the Group has achieved full or partial exits from 19 incubated companies.

Through the comprehensive upgrade of its three underlying modules, V-Scepter, V-Orb, and V-Mantle, the platform will significantly boost drug design efficiency and accelerate practical applications.

ITPS Canada Achieves NATO Flight Training Europe Accreditation

London, Ontario – Newsfile Corp. – August 26, 2026 – ITPS Canada Ltd., together with its subsidiaries, the International Test Pilots School (ITPS) and the International Tactical Training Centre (ITTC), has achieved accreditation under NATO Flight Training Europe (NFTE), following a comprehensive evaluation of its training capabilities and operating environment.

2026 School Photo at International Test Pilots School

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/9198/311371_itpsimage1.jpg

The accreditation marks an important milestone for ITPS Canada, providing independent recognition of the standards underpinning its international aerospace training operations. NATO Flight Training Europe is a multinational initiative designed to provide NATO nations with access to a network of high-quality military aviation training capabilities.

ITPS Canada’s accreditation places the organization within the NFTE framework and provides participating NATO air forces with a more direct mechanism to access accredited training delivered by ITPS and ITTC, spanning specialist flight test and aerospace training as well as advanced military flying and tactical training.

International Tactical Training Centre in North Bay, Ontario

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/9198/311371_itpsimage2.jpg

“This accreditation reflects how ITPS Canada has continued to grow while remaining focused on the standards and capabilities that have earned the trust of customers around the world,” said Giorgio Clementi, Executive Chairman, ITPS Canada Ltd. “We have continued to invest in our people, aircraft, simulation, infrastructure, and training methodologies to meet increasingly complex requirements. NFTE accreditation is an important endorsement of that investment and of the professional framework we have built across ITPS and ITTC.”

The NFTE accreditation process assesses training providers against demanding criteria spanning aviation safety, training quality, governance and supervision, regulatory compliance, operational delivery, infrastructure, and duty of care. Accreditation provides customers with additional assurance that ITPS Canada’s training environments meet the standards expected for military aviation training within the NATO framework.

ITPS provides specialist flight test and aerospace training for test pilots, flight test engineers and associated specialists. ITTC, based in North Bay, Ontario, provides advanced military flying and tactical training for fighter aircrew preparing for increasingly complex operational environments.

International Test Pilots School in London, Ontario

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/9198/311371_itpsimage3.jpg

Together, these capabilities represent a growing Canadian sovereign pilot training capability, expanding the capacity available within Canada to support domestic, NATO and Allied air force requirements. ITTC’s investment in advanced training capabilities, including the Leonardo M-346 Block 20 Advanced Jet Trainer, further builds Canada’s domestic training capacity while strengthening ITPS Canada’s ability to support the requirements of modern air forces.

“This accreditation recognizes the professionalism, discipline and operational focus that define both ITPS and ITTC,” said Dave Lohse, CEO, ITPS Canada. “Our teams have worked diligently to build training environments that meet the highest international standards, with safety underpinning everything we do. We are proud to support NATO and Allied partners while contributing to the readiness and interoperability required for collective defence.”

“CCC is pleased that ITPS has achieved NATO’s accreditation, a significant milestone that reflects the company’s world-class expertise, innovation, and commitment to excellence in pilot training. This recognition positions ITPS for continued growth with Canada’s allies and like-minded nations. We look forward to securing more government-to-government (G2G) contracts with ITPS to help expand the reach of their training around the world.” – Bobby Kwon, President and CEO of CCC.

As NATO and Allied air forces face growing demand for highly qualified aircrew, ITPS Canada will continue investing in its aircraft fleets, synthetic training systems, instructional capability, facilities, and people. Through ITPS and ITTC, the organization is positioned to contribute additional training capacity across the Alliance and support the operational readiness of NATO and Allied air forces.

ITPS Canada extends its appreciation to NATO Flight Training Europe and the Accreditation Team for their thorough evaluation and continued collaboration.

– 30 –
Media Contact
Sheila Hodgson
Director, Sales and Marketing
press@itpscanada.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/311371

The issuer is solely responsible for the content of this announcement.